Learn the latest Ebola and Andes virus update, current Centers for Disease Control and Prevention screening guidance, and how Norton Healthcare is preparing and responding.

Published: June 19, 2026

The risk of exposure to Ebola virus and Andes virus — a type of hantavirus — remains low in the United States. As of this update, no cases have been identified domestically.

While global surveillance continues and outbreaks in other regions may generate patient questions or clinical concern, there is currently no elevated threat to patients or staff in our facilities.

The Epic Travel Screen OPA criteria automatically update based on Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) guidance, so screening workflows remain current without manual intervention.

What Norton Healthcare’s Infection Prevention team is doing

Our Infection Prevention team is actively coordinating with Kentucky and Indiana health departments to ensure that recommended protocols are in place and that our facilities are prepared to respond appropriately if the situation changes.

What you should do

• Share this update with your team. Keep your colleagues informed so everyone is operating from the same baseline.
• Direct clinical questions to the Infection Prevention team by emailing IP@nortonhealthcare.org.

CDC clinical resources

Ebola

• Clinical guidance for Ebola
• Clinical screening and diagnosis for viral hemorrhagic fevers
• Clinical treatment of viral hemorrhagic fevers (VHFs)

Hantavirus (Andes virus)

• Clinical overview of hantavirus
• Clinician brief: Hantavirus pulmonary syndrome (HPS)

Questions?

Contact Infection Prevention at [email protected].